Quantcast
Home > Quotes > CYTK
CYTK

Cytokinetics, Incorporated Common Stock (CYTK) Quote & Summary Data

$6.5
*  
0.12
1.81%
Get CYTK Alerts
*Delayed - data as of Nov. 13, 2018  -  Find a broker to begin trading CYTK now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
N/A / N/A
1 Year Target
12
Today's High / Low
$ 6.76 / $ 6.48
Share Volume
285,054
50 Day Avg. Daily Volume
386,415
Previous Close
$ 6.62
52 Week High / Low
$ 12.50 / $ 6.205
Market Cap
355,081,981
P/E Ratio
NE
Forward P/E (1y)
NE
Earnings Per Share (EPS)
$ -2.22
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
1.26

Intraday Chart

Shares Traded

Share Volume:
285,054
50 Day Avg. Daily Volume:
386,415

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
NE
Earnings Per Share (EPS):
$ -2.22

Trading Range

The current last sale of $6.50 is 4.75% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 6.76 $ 12.50
 Low: $ 6.48 $ 6.205

Company Description (as filed with the SEC)

When used in this report, unless otherwise indicated, "Cytokinetics," "the Company," "we," "our" and "us" refers to Cytokinetics, Incorporated. CYTOKINETICS, and our logo used alone and with the mark CYTOKINETICS, are registered service marks and trademarks of Cytokinetics. Other service marks, trademarks and trade names referred to in this report are the property of their respective owners. 2 -------------------------------------------------------------------------------- Overview We were incorporated in Delaware in August 1997 as Cytokinetics, Incorporated. We are a late-stage biopharmaceutical company focused on the discovery and development of first-in-class muscle activators as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining.  ... More ...  


Risk Grade

Where does CYTK fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 6.71
Open Date:
Nov. 13, 2018
Close Price:
$ 6.50
Close Date:
Nov. 13, 2018

Consensus Recommendation

Analyst Info



Another Bailout?? Why is the SEC boosting big banks and HFT's bottom lines?
x